We validated EphA2 expression in sarcoma cell lines available in our laboratory (Figure 3A) and tested EphA2‐CAR‐NK cells against these cell lines using a Calcein AM cytotoxicity assay. This evidence concerns the gene EPHA2 and sarcoma.